High content imaging (HCI) and analysis of 3D in vitro models, such as organoids and spheroid cultures, provide invaluable information that give you greater insights into complex disease pathophysiology for more effective assessment of novel compounds and new therapeutic modalities. Continue reading to learn more about testing compounds for oncology, immuno-oncology, inflammation, and cystopathy indications.
A 3D high content imaging-based screening assay for evaluating monotherapy and combination drug responses in patient tumors with preserved native tumor microenvironment.
Detect more than 500 different morphological parameters of 3D in vitro models using our powerful high content screening services
© 2023 Crown Bioscience. All Rights Reserved.
© 2023 Crown Bioscience. All Rights Reserved. Privacy Policy